Intravenous Administration of Microplasmin for Treatment of Acute Ischemic Stroke
Completed
Phase 2 ResultsView Trial Locations
Recruitment
- Enrollment: 40
- Gender: Both
- Minimum Age: 18 Years
- Accepts Healthy Volunteers: No
- 16 locations, 3 countries
Principal Investigator
- Vincent Thijs, MD PhD
KU Leuven